SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
51203The shorts keep saying that FGEN is hiding something, and some of Dr. Yu's abmaz001-11/12/2019
51202Shorts getting a little desperate you think? For fraud like that to occur, SIX semi_infinite 211/12/2019
51201The barrage continues: FibroGen sinks after Muddy Waters highlights short reporbmaz001111/12/2019
51200As I recall, Dr Yu said the FDA didn't require experiments to be powered to A.J. Mullen111/12/2019
51199I didn't bother listening. Were there any questions that weren't coveresemi_infinite -11/12/2019
51198Regarding the FGEN call yesterday, I could feel my blood pressure rise as Dr. Yubmaz001-11/12/2019
51197The definition on page 14 of this presentation fibrogen.gcs-web.com is what I unmouton29-11/11/2019
51196FGEN - does anyone have a link to the safety results from the individual NDD triatticus4paws-11/11/2019
51195Goldman Sachs still isn't buying the FGEN story. I've posted their commebmaz001111/11/2019
51194Thanks! That seems like the best approach especially seeing today's price acdna_joe-11/11/2019
51193I still believe that buying FGEN shares is better than buying call options. HowArt Bechhoefer-11/11/2019
51192$FGEN Looking at buying some Jan 21 call options tomorrow, possibly the $45 calldna_joe-11/10/2019
51191I've uploaded my AMRN cheat sheet if anyone is interested. Vitals, News, Twibmaz001311/10/2019
51190Time will tell, Dew. As an owner of a few AMRN shares, I'm just hoping that bmaz001-11/10/2019
51189My own bear thesis for AMRN is that Vascepa sales following the FDA label expansDewDiligence_on_SI-11/10/2019
51188AMRN/Vascepa Feeling spoiled. FGEN one week and AMRN the next (Adcom on Thursdabmaz001-11/10/2019
51187It was clear that the Plainview push was a fraud. Ascribing no value to PamrevluMarmoset-11/9/2019
51186Think FGEN still cheap here (assuming no huge jump on Monday). Key unknown forBiomaven-11/9/2019
51185Yesterday was definitely a step in the right direction for FGEN. Given how populbmaz001-11/9/2019
51184NDD was a close call. It's a big untapped market, so if FGEN can get it, ittuck211/8/2019
51183After the article by Plainview, there was concern that it might be a scam. The A.J. Mullen-11/8/2019
51182With all respect to Mr. Neff, he sounded very, very ill on that call. I think tatticus4paws-11/8/2019
51181Now I understand why the FGEN conference call in May was such a mess. Mr. Neff wbmaz001-11/8/2019
51180Plainview was quiet, as expected, on Twitter today. No real web presence. No fatticus4paws-11/8/2019
51179I wasn't buying because I already have what I consider to be a full positionbmaz001-11/8/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News